- Home
- NPT vs DXR Comparison
NPT vs DXR Comparison
Compare NPT & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NPT | DXR |
|---|---|---|
| Founded | 2011 | 1970 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.5M | 59.0M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | NPT | DXR |
|---|---|---|
| Price | $3.87 | $10.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 84.7K | 1.7K |
| Earning Date | 05-23-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.14 | $8.56 |
| 52 Week High | $22.38 | $14.76 |
Technical Indicators
Market Signals| Indicator | NPT | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 76.30 | 50.12 |
| Support Level | $3.58 | $9.79 |
| Resistance Level | $5.96 | $10.99 |
| Average True Range (ATR) | 0.22 | 0.44 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 93.96 | 19.89 |
Price Performance
Historical ComparisonAbout NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.